4
Changes in Ownership
COLLEGIUM PHARMACEUTICAL, INC Filed Acc 0001062993-22-024501
Director sold 25,041 shares at an average $23.58 ($590,451)
- Director acquired 25,041 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Heffernan Michael Thomas · Director
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-12-22 | Exercise or conversion : show line 1 in the form | +237 | $16.15 | $3,828 | 28,260 | D |
| 2022-12-22 | Sale : show line 2 in the form | −237 | $23.00 | $5,451 | 28,023 | D |
| 2022-12-23 | Exercise or conversion : show line 3 in the form | +4,989 | $16.15 | $80,572 | 33,012 | D |
| 2022-12-23 | Sale : show line 4 in the form | −4,989 | $23.00 | $114,747 | 28,023 | D |
| 2022-12-27 | Exercise or conversion : show line 5 in the form | +15,995 | $16.15 | $258,319 | 44,018 | D |
| 2022-12-27 | Sale : show line 6 in the form | −15,995 | $23.63 | $377,962 | 28,023 | D |
| 2022-12-27 | Exercise or conversion : show line 7 in the form | +3,820 | $16.15 | $61,693 | 31,843 | D |
| 2022-12-27 | Sale : show line 8 in the form | −3,820 | $24.16 | $92,291 | 28,023 | D |
| Open-market sales · 25,041 sh · avg $23.58 · $590,451 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-12-22 | Exercise or conversion : show line 9 in the form Stock Option (Right to Purchase) | −237 | 24,804 | D |
| 2022-12-23 | Exercise or conversion : show line 10 in the form Stock Option (Right to Purchase) | −4,989 | 19,815 | D |
| 2022-12-27 | Exercise or conversion : show line 11 in the form Stock Option (Right to Purchase) | −15,995 | 3,820 | D |
| 2022-12-27 | Exercise or conversion : show line 12 in the form Stock Option (Right to Purchase) | −3,820 | 0 | D |
Loading xslF345X03/form4.xml…